CytoMed Therapeutics Limited
Stock Forecast, Prediction & Price Target

CytoMed Therapeutics Limited Financial Estimates

CytoMed Therapeutics Limited Revenue Estimates

CytoMed Therapeutics Limited EBITDA Estimates

CytoMed Therapeutics Limited Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025
Revenue
 
% change YoY
$113.84K
 
N/A
$363.91K
 
219.66%
$290.56K
 
-20.15%
Avg: $690.90K
Low: $690.90K
High: $690.90K
avg. 137.78%
Net Income
 
% change YoY
$-2.07M
 
N/A
$-3.22M
 
-55.59%
$-3.13M
 
2.97%
Avg: $-3.53M
Low: $-3.53M
High: $-3.53M
avg. -12.74%
EBITDA
 
% change YoY
$-1.60M
 
N/A
$-1.49M
 
6.99%
$-2.93M
 
-96.49%
Avg: $-414.54K
Low: $-414.54K
High: $-414.54K
avg. 85.88%
EPS
 
% change YoY
-$0.3
 
N/A
-$0.41
 
-36.66%
-$0.29
 
29.26%
Avg: -$0.33
Low: -$0.33
High: -$0.33
avg. -14.54%
Operating Expenses
 
% change YoY
$1.72M
 
N/A
$1.85M
 
7.42%
$3.12M
 
68.13%
Avg: $1.57M
Low: $1.57M
High: $1.57M
avg. -49.62%

FAQ

What is CytoMed Therapeutics Limited stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -12.74% in 2025-2025.

We have gathered data from N/A analysts. Their low estimate is -3.53M, average is -3.53M and high is -3.53M.

What is CytoMed Therapeutics Limited stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 137.78% in 2025-2025.

We have gathered data from N/A analysts. Their low revenue estimate is $690.90K, average is $690.90K and high is $690.90K.

What is CytoMed Therapeutics Limited stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -14.54% in 2025-2025.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.33, average is -$0.33 and high is $-0.33.